Magle Chemoswed Holding

4.22 SEK

+2.93 %

Less than 1K followers

MAGLE

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

+2.93 %
-7.46 %
-53.11 %
-76.02 %
-77.19 %
-83.89 %
-87.96 %
-88.23 %
-79.00 %

The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. The Group includes three operational areas. Magle Chemoswed, a contract development and manufacturing organization (CDMO). Magle PharmaCept, an established sales and marketing company for the development and direct sales of the Groups medical technology products, and Magle Biopolymers A/S, a specialized manufacturing organization of Dextran technology.

Read more
Market cap
127.71M SEK
Turnover
150.1 SEK
Revenue
282.92M
EBIT %
-44.88 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.5
2026

General meeting '26

26.5
2026

Extraordinary general meeting '26

31.5
2026

Interim report Q1'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.